The Multiple Sclerosis Association of America (MSAA) is pleased to present its latest edition of “What’s New in MS Research.” This series of online articles is published periodically and features important information on topics ranging from highlights of major international MS conferences and updates on trials with experimental disease-modifying therapies, to new findings on the development of the disease, symptom management, and quality-of-life issues.

This latest edition of “What’s New in MS Research” features important MS updates, including results from recent studies. Topics include:

• Cell therapy for treatment-resistant progressive MS receives FDA Fast Track designation

• Online cognitive behavior therapy (CBT) may ease depressive symptoms in people with MS

• Geographical mapping shows disparities in access to MS care

• How MS disease course may differ by timing of onset

• And other vital topics

Please read MSAA’s latest edition of "What’s New in MS Research." We hope you find these updates to be both informative and encouraging, providing help and hope to the entire MS community.